Fuentespina, Cecil C.
HRN: 21-50-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
CEFUROXIME 500MG (TAB)
06/18/2022
06/24/2022
ORAL
500mg
BID
Increased Wbc 12.1; S/p RCS With Bilateral Salpingectomy
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes